News and Trends 14 Jun 2017 French Hepatitis Cure is on Track with Positive Phase I Results …thereby outperforms established therapies such as Tenofovir (Gilead) and Entecavir (BMS). Genome of the hepatitis B virus According to the WHO, more than 350M people are chronically infected with hepatitis… June 14, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 29 Aug 2025 Can genetically modified crops help us adapt to climate change? …future of food and farming by extensively patenting plants and portfolios of new genetically modified organism techniques. For example, Corteva holds a patent for a process modifying the genome of… August 29, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2022 Touchlight receives new grant to further develop doggybone DNA vaccine platform …DNA is already widely utilized across the genetic medicine market, in areas such as critical starting material for viral vector and mRNA vaccine production, genome editing and DNA vaccine applications…. November 29, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Apr 2023 Six synthetic biology companies that have made a mark …a billion dollars without being listed on the stock market. Ribbon Biolabs Founded five years ago, Ribbon Biolabs specializes in building entire genomes, CRISPR libraries as well as developing DNA-based… April 28, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 29 Nov 2017 What’s Going on in the Biotech Ecosystem of Portugal? …support system based on a patient’s genome sequence, Perceive3D using computer vision to assist the surgeon during minimally invasive procedures, Peek Health for 3D orthopedic surgical planning tools and Tonic… November 29, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2022 EditForce and Mitsubishi Tanabi Pharma to work on gene therapy for CNS …a specific target DNA or RNA sequence. It is possible to manipulate and modify the target genome and RNA both inside and outside the cell by fusion with effector proteins…. July 5, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Mar 2025 Top biotech deals of February 2025 …non-mutated, aberrantly expressed antigens that are derived from what were thought to be non-coding regions of the genome, which is also called junk DNA. Another big pharma in the RNA… March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2017 Demo Day: Meet the Latest Generation of Synbio Startups from RebelBio …which developed a plant genome editing platform with CRISPR to make designer foods that don’t carry a GMO tag. Their first project is a soy plant with an oil composition… August 4, 2017 - 6 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A …HAYA Therapeutics, based in Switzerland, has partnered with Lilly, based in the United States, to discover genome targets for metabolic diseases. HAYA is set to receive up to $1 billion… March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2018 UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy …find out which role they play in a particular health condition. In particular, Microbiotica is using its reference culture collection and genome database to develop medicines and diagnostic targets in… October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2022 GenScript and Avectas look to improve non-viral cell therapy manufacturing …the generation of engineered ex vivo cell-based therapies, including genome editing approaches. But the limitations of current delivery modalities, both viral and non-viral, led Avectas to develop the non-viral SOLUPORE… September 20, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 6 Oct 2023 Beyond Biotech podcast 66 – treating rare diseases with tRNA …at ASGCT the first demonstration that an engineered, modified tRNA could recognize and correct, in vivo, a flawed mRNA instruction no matter where it occurred in the genome. Alltrna, which… October 6, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email